HAEMATOLOGIC TECHNOLOGIES, INC.

Address

57 RIVER RD UNIT 1021
ESSEX JUNCTION, VT, 05452-3842

http://www.haemtech.com

Information

DUNS: 192057123
# of Employees: 46

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. A Global Test of Hemostatic Risk

    Amount: $351,562.00

    DESCRIPTION (provided by applicant): Phase I funding for this project supported successful studies that were aimed at demonstrating the feasibility of developing an easy to use, global test in the are ...

    STTRPhase II2007Department of Health and Human Services
  2. Murine Reagents and Analytical Tools

    Amount: $681,228.00

    DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model sys ...

    SBIRPhase II2005Department of Health and Human Services
  3. Fluorogenic Assays for Factor Vlla and Tissue Factor

    Amount: $328,891.00

    DESCRIPTION (provided by applicant): Factor VIIa and tissue factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed o ...

    SBIRPhase II2005Department of Health and Human Services
  4. A Global Test of Hemostatic Risk

    Amount: $99,039.00

    DESCRIPTION (provided by applicant): Although the vast majority of patients who suffer from venous or arterial thrombosis have haemostatic systems that fall within the "normal" range of routine screen ...

    STTRPhase I2004Department of Health and Human Services
  5. Murine Reagents and Analytical Tools

    Amount: $75,000.00

    DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model sys ...

    SBIRPhase I2003Department of Health and Human Services
  6. Fluorogenic Assays for Factor Vlla and Tissue Factor

    Amount: $74,217.00

    DESCRIPTION (provided by applicant): Factor Vlla and Tissue Factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed o ...

    SBIRPhase I2003Department of Health and Human Services
  7. Assay for In Vivo Activated Protein C (APC) Activity

    Amount: $58,396.00

    In the area of clinical coagulation research, much attention is focused on the molecular eventswhich occur before, during, and after anticoagulant and antithrombotic therapies. For purposes ofmonitori ...

    SBIRPhase I1994Department of Health and Human Services
  8. Specific Inhibitors of Activated Protein C

    Amount: $74,065.00

    Factors V and VIII are procofactors which are essential components of the blood coagulationprocess. Deficiency in either of these proteins is associated with severe bleeding disorders, hemophiliaand p ...

    SBIRPhase I1994Department of Health and Human Services
  9. SELECTIVE CAPTURE AND QUANTITATION OF SERINE PROTEASES

    Amount: $500,000.00

    THROMBOSIS AND THROMBOLYSIS ARE MAINTAINED IN A DELICATE BALANCE BY A SERIES OF ENZYMATIC REACTIONS. THE COMPONENT ENZYMES ARE PRODUCED AS NEEDED FROM ZYMOGENS, INACTIVE FORMS THAT CIRCULATE IN THE BL ...

    SBIRPhase II1990Department of Health and Human Services
  10. IMMUNOASSAY FOR OSTEOCALCIN FRAGMENTS

    Amount: $46,139.00

    CURRENTLY, AN ASSAY TO MEASURE THE RATE OF BONE RESORPTION IN AN EASY AND REPRODUCIBLE MANNER DOES NOT EXIST. OSTEOCALCIN, A BONE-SPECIFIC PROTEIN, IS ASSAYED AS A MARKER OF BONE FORMATION. SINCE THER ...

    SBIRPhase I1989Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government